» Articles » PMID: 35414037

Overall and Sex-specific Risk Factors for Subjective Cognitive Decline: Findings from the 2015-2018 Behavioral Risk Factor Surveillance System Survey

Overview
Journal Biol Sex Differ
Publisher Biomed Central
Specialties Biology
Physiology
Date 2022 Apr 13
PMID 35414037
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prior research indicates that at least 35% of Alzheimer's disease and related dementia risk may be amenable to prevention. Subjective cognitive decline is often the first indication of preclinical dementia, with the risk of subsequent Alzheimer's disease in such individuals being greater in women than men. We wished to understand how modifiable factors are associated with subjective cognitive decline, and whether differences exist by sex.

Methods: Data were collected from men and women (45 years and older) who completed the U.S. Behavioral Risk Factor Surveillance System Cognitive Decline Module (2015-2018), n = 216,838. We calculated population-attributable fractions for subjective cognitive decline, stratified by sex, of the following factors: limited education, deafness, social isolation, depression, smoking, physical inactivity, obesity, hypertension, and diabetes. Our models were adjusted for age, race, income, employment, marital and Veteran status, and accounted for communality among risk factors.

Results: The final study sample included more women (53.7%) than men, but both had a similar prevalence of subjective cognitive decline (10.6% of women versus 11.2% of men). Women and men had nearly equivalent overall population-attributable fractions to explain subjective cognitive decline (39.7% for women versus 41.3% for men). The top three contributing risk factors were social isolation, depression, and hypertension, which explained three-quarters of the overall population-attributable fraction.

Conclusions: While we did not identify any differences in modifiable factors between men and women contributing to subjective cognitive decline, other factors including reproductive or endocrinological health history or biological factors that interact with sex to modify risk warrant further research.

Citing Articles

How preclinical models of menopause can inform clinical care: A focus on midlife and reciprocal communication between clinical and preclinical science.

Bimonte-Nelson H, Bernaud V Curr Opin Endocr Metab Res. 2024; 28.

PMID: 39484630 PMC: 11526845. DOI: 10.1016/j.coemr.2023.100434.


Prevalence and risk factors of subjective cognitive decline in older adults in Baotou, China: a cross-sectional study.

Ma S, Yu Y, Tian K, Yong W, Yu W, Bai R Front Aging Neurosci. 2024; 16:1422258.

PMID: 39444802 PMC: 11496101. DOI: 10.3389/fnagi.2024.1422258.


Cognitive Symptoms Across Diverse Cancers.

Mayo S, Edelstein K, Atenafu E, Ajaj R, Li M, Bernstein L JAMA Netw Open. 2024; 7(8):e2430833.

PMID: 39196555 PMC: 11358862. DOI: 10.1001/jamanetworkopen.2024.30833.


Herpes zoster and long-term risk of subjective cognitive decline.

Yeh T, Curhan G, Yawn B, Willett W, Curhan S Alzheimers Res Ther. 2024; 16(1):180.

PMID: 39138535 PMC: 11323373. DOI: 10.1186/s13195-024-01511-x.


Cognitive and immunological effects of yoga compared to memory training in older women at risk for alzheimer's disease.

Grzenda A, Siddarth P, Milillo M, Aguilar-Faustino Y, Khalsa D, Lavretsky H Transl Psychiatry. 2024; 14(1):96.

PMID: 38355715 PMC: 10867110. DOI: 10.1038/s41398-024-02807-0.


References
1.
Jessen F, Amariglio R, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G . A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014; 10(6):844-52. PMC: 4317324. DOI: 10.1016/j.jalz.2014.01.001. View

2.
El Khoudary S, Greendale G, Crawford S, Avis N, Brooks M, Thurston R . The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN). Menopause. 2019; 26(10):1213-1227. PMC: 6784846. DOI: 10.1097/GME.0000000000001424. View

3.
Diaz-Galvan P, Ferreira D, Cedres N, Falahati F, Hernandez-Cabrera J, Ames D . Comparing different approaches for operationalizing subjective cognitive decline: impact on syndromic and biomarker profiles. Sci Rep. 2021; 11(1):4356. PMC: 7902653. DOI: 10.1038/s41598-021-83428-1. View

4.
Barnes D, Yaffe K . The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011; 10(9):819-28. PMC: 3647614. DOI: 10.1016/S1474-4422(11)70072-2. View

5.
Krause-Sorio B, Siddarth P, Kilpatrick L, Milillo M, Aguilar-Faustino Y, Ercoli L . Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial. J Alzheimers Dis. 2022; 87(2):569-581. PMC: 9198760. DOI: 10.3233/JAD-215563. View